We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to ... Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. Show more
Revelation Biosciences, Inc. (NASDAQ: REVB) (the βCompanyβ or βRevelationβ), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment...
-Phase 1b Study in CKD Patients to begin early 2025- Revelation Biosciences, Inc. (NASDAQ: REVB) (the βCompanyβ or βRevelationβ), a clinical-stage life sciences company that is focused on...
Revelation Biosciences, Inc. (NASDAQ: REVB) (the βCompanyβ or βRevelationβ), a clinical-stage biopharmaceutical company focused on harnessing the power of trained immunity for the prevention and...
Revelation Biosciences, Inc. (NASDAQ: REVB) (the βCompanyβ or βRevelationβ), a clinical-stage biopharmaceutical company focused on harnessing the power of trained immunity for the prevention and...
Revelation Biosciences, Inc. (NASDAQ: REVB) (the βCompanyβ or βRevelationβ), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention...
Revelation Biosciences Inc. (NASDAQ: REVB) (the βCompanyβ or βRevelationβ), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of...
Revelation Biosciences, Inc. (NASDAQ: REVB) (the βCompanyβ or βRevelationβ), a clinical-stage biopharmaceutical company focused on harnessing the power of trained immunity for the prevention and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0721 | -16.2717219589 | 0.4431 | 0.465 | 0.3606 | 512612 | 0.43339137 | CS |
4 | -0.4405 | -54.2821934689 | 0.8115 | 0.976 | 0.3606 | 1635157 | 0.67032959 | CS |
12 | -0.499 | -57.3563218391 | 0.87 | 1.05 | 0.3606 | 1040904 | 0.81616889 | CS |
26 | -1.919 | -83.7991266376 | 2.29 | 3.8 | 0.3606 | 1573477 | 1.6856617 | CS |
52 | -15.829 | -97.7098765432 | 16.2 | 25.26 | 0.3606 | 925522 | 2.44109725 | CS |
156 | -8798.629 | -99.9957836118 | 8799 | 10237.5 | 0.3606 | 1273007 | 771.75728195 | CS |
260 | -8798.629 | -99.9957836118 | 8799 | 10237.5 | 0.3606 | 1273007 | 771.75728195 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions